Sort
82,697 grants matching “vaccine development”
Development of a Group B Streptococcus bioconjugate vaccine
$1,000,000Christian Harding · Vaxnewmo, Llc · R44 · FY2023 · AI
Development of a ZIKA viral pseudoinfectious virus as ZIKA vaccine candidate (STTR Phase II)
$1,000,000Xiaowu Pang · Tengen Biomedical Co. · R42 · FY2022 · AI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine
$1,000,000Kenneth C Bagley · Orlance, Inc. · R44 · FY2021 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites
$1,000,000Sumana Chakravarty · Sanaria, Inc. · U44 · FY2025 · AI
SIRPant Technology for anti-Cancer Immunity
$1,000,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2023 · CA
Protective vaccine for H5N1 Flu using H5 protein and a novel TLR4 agonist.
$1,000,000Christopher H Clegg · Tria Bioscience Corporation · R44 · FY2012 · AI
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
$1,000,000Mark E McDonnell · Fox Chase Chemical Diversity Center, Inc · R44 · FY2025 · AI
HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development
$1,000,000Christos J Petropoulos · Monogram Biosciences, Inc. · R44 · FY2008 · AI
Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials
$1,000,000Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2016 · AI
Treatment of Inflammatory Complications of Respiratory Infection
$1,000,000Timothy J Pelura · Respana Therapeutics, Inc. · R42 · FY2023 · AI
A next-generation meningococcal serogroup B vaccine with improved effectiveness for all age groups
$1,000,000Gregory Robert Moe · Omvax, Inc. · R44 · FY2022 · AI
A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products
$1,000,000Peter F. Billingsley · Sanaria, Inc. · R44 · FY2022 · AI
Advancement of antiviral inhibitors of chikungunya virus
$1,000,000Daniel C Pevear · Venatorx Pharmaceuticals, Inc. · R44 · FY2021 · AI
SIRTUIN AGONISTS AS PAN INFLUENZA ANTIVIRALS
$1,000,000Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2018 · AI
UAB AIEDRP: Immune Control and Escape in Acute Infection
$1,000,000University Of Alabama At Birmingham · U01 · FY2005 · AI
Portable electronically controlled transdermal patch for enfuvirtide delivery
$1,000,000Maureen L. Mulvihill · Actuated Medical, Inc. · R44 · FY2013 · AI
A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products
$1,000,000Peter F. Billingsley · Sanaria, Inc. · R44 · FY2021 · AI
Preclinical development of an immunomodulatory agent capable of mitigating SARS-CoV-2 virus related hypercytokinemia
$1,000,000Jodi K Craigo · Cytoagents, Inc. · R44 · FY2021 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · R44 · FY2021 · AI
Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer
$1,000,000Yicheng Wang · Immunova Therapeutics, Llc · R44 · FY2022 · CA
A capsule-based bioconjugate vaccine to prevent Klebsiella pneumoniae infections
$1,000,000Christian Harding · Vaxnewmo, Llc · R44 · FY2025 · AI
Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs
$1,000,000Janet L Huie · Jan Biotech, Inc. · R44 · FY2025 · AI
HIV pathogenesis, prevention and treatment in the Andes
$1,000,000Asociacion Civil Impacta Salud Y Educacn · U19 · FY2004 · AI
Chikungunya Recombinant Subunit Vaccine
$1,000,000David E. Clements · Hawaii Biotech, Inc. · R44 · FY2021 · AI
A Vaccine for Lymphatic Filariasis, LFGuardâ¢
$1,000,000Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2020 · AI